Zobrazeno 1 - 10
of 227
pro vyhledávání: '"H.A. Valantine"'
Autor:
J.F. Goldberg, C.R. deFilippi, C. Lockhart, E.R. McNair, S. Sinha, H. Kong, S.S. Najjar, B.J. Lohmar, I. Tchoukina, K. Shah, E. Feller, S. Hsu, M.E. Rodrigo, M. Jang, C. Marboe, G.J. Berry, H.A. Valantine, S. Agbor-Enoh, P. Shah
Publikováno v:
The Journal of Heart and Lung Transplantation. 42:S67-S68
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
A.M. Bon, E.F. Gerhard, J. Mathew, H. Kong, M.K. Jang, L. Henry, B.S. Lee, S. Hsu, K. Shah, I. Tchoukina, S. Sterling, M.E. Rodrigo, S. Najjar, C. Marboe, G.J. Berry, H.A. Valantine, P. Shah, S. Agbor-Enoh
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S478
Autor:
P. Shah, S. Agbor-Enoh, P. Bagchi, C.R. deFilippi, A. Mercado, G. Diao, D.J. Morales, K.B. Shah, S.S. Najjar, E. Feller, S. Hsu, M.E. Rodrigo, S.C. Lewsey, M.K. Jang, C. Marboe, G.J. Berry, K.K. Khush, H.A. Valantine
Publikováno v:
The Journal of Heart and Lung Transplantation. 41:S93
Autor:
C. Marboe, J. Matthews, Anne Brown, A. Charya, Junfeng Sun, Sean Agbor-Enoh, Helen Luikart, G. Berry, J.B. Orens, Aldo Iacono, H. Kong, C. Mutebi, Palak Shah, H.A. Valantine, Ilker Tunc, Moon Kyoo Jang, Steven D. Nathan, Kiran K. Khush
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S157-S158
Purpose Maintenance of immunosuppression in lung transplant recipients (LTx) is integral for preventing allograft rejection, with tacrolimus as a mainstay drug. Prior research from our group showed significantly poorer outcomes for Non-European Ances
Autor:
J. Matthews, Aldo Iacono, Anne Brown, I. Timofte, Ilker Tunc, A. Marishta, Kiran K. Khush, C. Marboe, Sean Agbor-Enoh, A. Charya, U. Fideli, Pali D. Shah, Moon Kyoo Jang, H.A. Valantine, Yanqin Yang, Steven D. Nathan, K. Bhatti, Helen Luikart, G. Berry, J.B. Orens, H. Kong
Publikováno v:
The Journal of Heart and Lung Transplantation. 39:S55-S56
Purpose African American patients (AA) have poorer outcomes than White patients (W) after heart and kidney transplant. Little is known about differential outcomes in lung transplantation (LTx). This study compares allograft injury and chronic allogra
Autor:
Yanqin Yang, T. Ilker, Steven Hsu, Maria E. Rodrigo, Erika D. Feller, G. Berry, Pali D. Shah, H. Kong, Stuart D. Russell, Mehdi Pirooznia, H.A. Valantine, Samer S. Najjar, Keyur B. Shah, Charles C. Marboe, Sean Agbor-Enoh, Moon Kyoo Jang
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S254
Purpose Higher rates of acute rejection in African American transplant recipients are reported across multiple organ types. Mechanisms underlying poorer outcomes vs. other races are poorly defined. Because race is a social construct, most studies use
Autor:
Aldo Iacono, H.A. Valantine, Helen Luikart, Kiran K. Khush, Sean Agbor-Enoh, Ilker Tunc, Steven D. Nathan, C. Marboe, A. Charya, Pali D. Shah, Moon Kyoo Jang, Anne Brown, G. Berry, C. Mutebi, J.B. Orens, H. Kong, J. Matthews
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S62
Purpose Tacrolimus is a primary immunosuppressive drug used in lung transplantation (LTx). Unfortunately, significant variability in drug level monitoring and dosing makes it challenging to determine immunosuppression adequacy. Furthermore, the relat
Autor:
C. Mutebi, Aldo Iacono, H.A. Valantine, A. Cochrane, Deborah Levine, L. Ponor, J. Mathew, S. Nathan, Sean Agbor-Enoh, Anne Brown, Kiran K. Khush, G. Berry, J.B. Orens, H. Kong, Moon Kyoo Jang, Charles C. Marboe, Pali D. Shah, Helen Luikart
Publikováno v:
The Journal of Heart and Lung Transplantation. 40:S77
Purpose Patients who fail to respond to initial pulmonary antibody-mediated rejection (AMR) treatment may benefit from second generation therapies. Unfortunately, current approaches identify non-responders late after irreversible allograft loss and c